Cryobanks in America
A cryobank — also known as a sperm bank or semen bank — is a licensed medical facility that collects, screens, freezes, stores, and distributes human sperm for use in assisted reproductive technologies including intrauterine insemination (IUI), in vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI). The word “cryo” comes from the Greek word for cold — reflecting the liquid-nitrogen storage conditions that preserve donor sperm at approximately –196 degrees Celsius (–321°F) for years without degradation. In the United States, cryobanks are regulated as human cellular and tissue-based products under FDA regulations (21 CFR Part 1271), which mandate rigorous infectious disease testing, donor quarantine periods, and detailed medical record-keeping for every sample. The clients who use these facilities span a wide range: single women, same-sex female couples, heterosexual couples facing male-factor infertility, individuals preserving fertility before cancer treatment, and men freezing their own sperm before a vasectomy or deployment.
In 2026, the United States is the dominant player in the global cryobank market — both in terms of supply and exports. The US sperm bank market is valued at approximately $1.9 billion in 2026, anchored by major commercial operators — California Cryobank, Fairfax Cryobank, Seattle Sperm Bank, Cryos International USA, and Xytex — that supply donor sperm not just to American fertility clinics but to programs in Canada, Australia, the UK, and dozens of other countries where domestic sperm supply is constrained by laws prohibiting paid donation. The American model of compensated sperm donation has created a robust, highly screened donor supply that the rest of the world increasingly depends on — and it has also created a pricing structure that is among the most expensive for recipients anywhere in the world. Understanding cryobank statistics in the US in 2026 — pricing, donor economics, market scale, and key trends — is essential for anyone navigating the fertility system.
Interesting Facts About Cryobanks in the US 2026
US CRYOBANK FAST FACTS — 2026
================================
US Sperm Bank Market Value (2026) ████████████████████ $1.9 Billion
Global Sperm Bank Market (2026) ████████████████████ $5.38 Billion
Sperm Donor Acceptance Rate (US) ██ <5% of applicants
Applicants rejected at semen analysis ████████████ ~60% (quality fails)
Vial Price Range — US banks ████████████████████ $795–$2,195 per vial
Donor pay per approved donation ████████████████████ $70–$200 per visit
Max annual donor earnings ████████████████████ Up to $12,000–$18,000
IUI clinical pregnancy rate per cycle ████████████████████ 15–25%
Scale: Each █ ≈ ~5 percentage points or proportional units
| Fact | Statistic / Detail |
|---|---|
| US sperm bank market value (2026) | $1.9 billion — growing at CAGR of 3.52% to reach $2.26 billion by 2031 (Mordor Intelligence, May 2026) |
| Global sperm bank market (2026) | $5.38 billion — up from $5.15 billion in 2025 (Research and Markets, 2026) |
| North America sperm bank market (2024) | $2.2 billion — projected to reach $4.8 billion by 2034 at 8.2% CAGR (Emergen Research) |
| Sperm donor acceptance rate — US banks | Below 5% of all applicants are accepted into commercial donor programs (Ivy Surrogacy, April 2026) |
| Most common rejection cause | Semen quality — approximately 60% of applicants disqualified at the initial semen analysis alone |
| Vial price range — US cryobanks (2026) | $795 (Seattle Sperm Bank IUI A.R.T.) to $2,195 (California Cryobank Premium) per vial |
| Fairfax Cryobank vial price range | $1,300–$2,100 per vial — depending on prep type, expanded testing, and donor availability |
| Sperm donation price increase (2023–2025) | 40–80% increase at one major bank over just two years — documented in Fertility and Sterility (December 2025) |
| Donor compensation per approved donation | $70–$200 per visit at most US commercial banks (coparents.com, March 2026) |
| Maximum annual sperm donor earnings | Up to $12,000–$18,000 per year for top-earning donors at high-paying programs |
| Vials recommended per child | California Cryobank recommends at least 5 vials per child — national average is 3–4 insemination cycles per successful pregnancy |
| IUI clinical pregnancy rate per cycle | 15–25% per cycle — top clinics achieve up to 25% depending on patient age and protocol |
| Shipping cost per order | $150–$300 per shipment — added to the per-vial cost |
| Colorado — anonymous donation law (2025) | First US state to legally end anonymous sperm donation — effective 2025 — identity disclosed to donor-conceived adults at age 18 |
| Cryos International — female/single client share | 85% of Cryos International clients are lesbian couples or single women as of September 2025 (Wikipedia / The Guardian) |
| Known/ID-release donors’ market share (2024) | 58.84% of the global sperm bank market — demand for transparent donor identity now dominates (Mordor Intelligence) |
| Private equity investment (December 2024) | Astorg closed a $228 million acquisition of Hamilton Thorne’s fertility-equipment division |
| California Cryobank waiting lists (2026) | Some donors have waiting lists exceeding 2,500 clients (Mordor Intelligence, May 2026) |
| US sperm export dominance | US is the world’s primary sperm exporter — supplies Canada, Australia, UK, and dozens of countries where paid donation is illegal |
| Sperm freezing segment share (2026) | Estimated ~42% of global sperm bank market revenue — fastest-growing service segment (Persistence Market Research) |
Source: Mordor Intelligence — United States Sperm Bank Market Report (May 2026); Research and Markets — Sperm Banks Market 2026 data; Emergen Research — North America forecast; Fertility and Sterility — “Cost of Donor Sperm in the United States: Historical and Contemporary Analysis” (December 2025); Ivy Surrogacy — Sperm Donor Requirements Guide (April 2, 2026); coparents.com — Sperm Donor Compensation (March 31, 2026); California Cryobank — Pricing Page; Wikipedia — Cryos International (September 2025); Mordor Intelligence — Global Sperm Bank Market 2030
The sub-5% acceptance rate for sperm donors at US commercial banks explains — better than any other single data point — why donor sperm in America is expensive. Major cryobanks receive hundreds of applicants for every donor slot they can fill, and the screening process is extraordinarily rigorous: semen analysis covering count, motility, and morphology; comprehensive physical examination; full FDA-mandated infectious disease blood panel; genetic carrier screening across dozens of heritable conditions; psychological evaluation; and detailed multi-generational medical history review. When 1 in 20 applicants passes all hurdles — with approximately 60% eliminated at semen quality alone — the cost of building and maintaining a qualified donor roster is genuine and substantial. Each accepted donor represents significant recruitment, screening, and administrative investment, and the vial price recipients pay covers all of it.
The 40–80% price increase documented in Fertility and Sterility at one major US bank between 2023 and 2025 reflects three converging forces: rising genetic screening costs as expanded panels test for more conditions, the shift toward ID-release donor programs that command higher prices due to greater demand, and general medical cost inflation. The Mordor Intelligence report from May 2026 noting that some California Cryobank donors now have waiting lists exceeding 2,500 clients illustrates the supply-demand imbalance driving this pricing escalation — recipients who find a preferred donor are increasingly advised to purchase and bank 5 or more vials upfront because popular donors sell out rapidly.
Sperm Vial Pricing by Major US Cryobanks in 2026
VIAL PRICE COMPARISON — MAJOR US CRYOBANKS (2026)
===================================================
California Cryobank (Premium ICI/IUI) ████████████████████████████████████████ $2,195
Fairfax Cryobank (upper range) ████████████████████████████████████████ $2,100
Fairfax Cryobank (lower range) ████████████████████████████ $1,300
Seattle Sperm Bank (IUI A.R.T.) ████████████████████████████ $1,395
Sperm Bank of California (washed) ████████████████████ $780–$855
Sperm Bank of California (unwashed) ████████████████████ $700–$775
+ Shipping: $150–$300 additional per order
Source: Bank pricing pages; rattlestork.org US bank comparison; coparents.com
Scale: Each █ ≈ ~$60
| Cryobank | Vial Type | Price Per Vial (2026) | Notable Details |
|---|---|---|---|
| California Cryobank | ICI / IUI / IVF / ICSI (Premium) | $2,195 | Top market pricing; free 1-year storage with 4+ vials; free 3-year storage with 8+ vials |
| Fairfax Cryobank | IUI / ICI (range) | $1,300–$2,100 | Price depends on prep type, expanded genetic panel, and donor availability; operating since 1986 |
| Seattle Sperm Bank | IUI A.R.T. (washed) | $1,395 | Claims lowest prices among major US banks; consistent pricing across donor types |
| Seattle Sperm Bank | ICI A.R.T. (unwashed) | $1,395 | Same price for washed and unwashed — simplifies recipient budgeting |
| Cryos International USA | Varies by donor/prep | ~€40–€1,600 ($48–$1,930) | World’s largest sperm bank by donor count; US locations in Florida, NC, Texas |
| The Sperm Bank of California | Washed vials | $780–$855 | Nonprofit institution; lowest mainstream pricing; $100/vial price increase April 2026 |
| The Sperm Bank of California | Unwashed vials | $700–$775 | 5% bulk discount on 6+ vials; registration $100 (standard) or $200 (express) |
| Fairfax Cryobank IUI (2023 → 2025) | IUI vial | $995 (2023) → $1,495 (2025) | 50% increase in two years — documented Fertility and Sterility (December 2025) |
| Fairfax Cryobank ICI (2023 → 2025) | ICI vial | $850 (2023) → $1,195 (2025) | 41% increase same two-year period |
| Cryobank America (updated Jan 1, 2026) | ICI A.R.T. | Listed per donor profile | First-year storage free; buyback option at 50% of purchase price within 1 year |
| Shipping cost (all banks) | Per order | $150–$300 | Overnight dry-shipper; adds materially to per-cycle total cost |
| Storage at recipient bank (Seattle example) | Annual | $500/year | 1 month: $125; 6 months: $300; 5 years: $1,250 |
Source: California Cryobank pricing page (cryobank.com); Seattle Sperm Bank — How Much Does Donor Sperm Cost; Fairfax Cryobank fees page (fairfaxcryobank.com); The Sperm Bank of California pricing; Cryobank America pricing page (updated January 1, 2026); rattlestork.org — Sperm Banks in the United States 2025 (October 2025); Fertility and Sterility — “Cost of Donor Sperm in the United States” (December 2025); Wikipedia — Cryos International (September 2025)
The per-vial pricing landscape across US cryobanks in 2026 is more complex than any headline number captures — the price a recipient pays compounds quickly once shipping, storage, clinic fees, and the need for multiple insemination cycles are factored in. At the top of the market, California Cryobank’s $2,195 per premium vial buys not just sperm but the deepest donor information, most extensive genetic screening, and the brand infrastructure of one of America’s oldest and largest commercial banks. At the accessible end, The Sperm Bank of California — a nonprofit — provides washed vials at $780–$855, making it the most affordable mainstream option while maintaining full FDA compliance. The $780-to-$2,195 spread represents a 181% price gap driven by donor profile depth, genetic testing breadth, pool size, and identity-management infrastructure rather than fundamental differences in clinical sperm quality standards. Given that the national average is 3–4 insemination cycles per successful pregnancy, a recipient using a mid-tier bank at $1,395 per vial faces approximately $4,185–$5,580 in vial costs alone before a single procedure, shipping, or storage fee is counted.
Sperm Donor Compensation & Requirements in the US 2026
SPERM DONOR COMPENSATION — US CRYOBANKS 2026
=============================================
Cryos International (per approved donation) ████████████████████ Up to $90
Typical commercial bank range (per visit) ████████████████████ $70–$200
donatesperm.com (maximum monthly) ████████████████████ Up to $1,400/month
Seattle/Fairfax range (monthly) ████████████████████ $1,000–$1,400/month
6-month program total earnings ████████████████████ $4,000–$8,400
Annual maximum (top programs) ████████████████████ $12,000–$18,000
Agency/known donation (per engagement) ████████████████████ $5,000–$50,000+
Acceptance rate: <5% of all applicants
Scale: Each █ ≈ ~$800 (earnings) or proportional
| Donor Compensation / Requirement | Statistic / Data |
|---|---|
| Compensation per approved donation — typical | $70–$200 per visit at most US commercial banks (coparents.com, March 2026) |
| Cryos International payment breakdown | $35 at donation + $30 if motility approved + $25 batch bonus = up to $90 per approved donation |
| Cryos International — max monthly earnings | Up to $720/month donating twice per week ($90 × 8 visits) |
| donatesperm.com — maximum monthly | Up to $1,400/month donating twice weekly — among highest-paying US programs |
| 6-month commitment total earnings | $4,000–$8,400 for standard 6-month program at mid-level compensation |
| Annual maximum — top-earning donors | Up to $12,000–$18,000 per year at highest-paying programs |
| Agency / known donation compensation | $5,000–$50,000+ per engagement — dramatically higher than bank donation (Ivy Surrogacy, April 2026) |
| Sperm donor acceptance rate | Below 5% of applicants accepted (Ivy Surrogacy, April 2026) |
| Primary rejection reason | Semen quality — ~60% of applicants disqualified at initial semen analysis |
| Donor age requirements (typical) | 18 to 39 years — some extend to 44; trend toward lowering upper limit to 35 |
| Height requirements (common) | Often 5’8″ or taller — not universal across all banks |
| FDA-mandated screening (21 CFR Part 1271) | All donors must complete testing for HIV, hepatitis B/C, syphilis, gonorrhea, chlamydia, CMV, and others |
| Quarantine period — anonymous donors | ~6 months — vials held, donor retested before release to clinics |
| ASRM ethics guidance on compensation | ASRM 2024: compensation must not be so high that money becomes the primary motivation |
| Tax treatment of donor compensation | Donors receive IRS Form 1099 — earnings are fully taxable income |
| Referral bonuses | Up to $300 per successful referral (donatesperm.com); varies by bank |
| Colorado ID-disclosure law (effective 2025) | First US state to legally ban anonymous sperm donation; identity disclosed at offspring age 18 |
| ID-release donor demand | ID-release donors command higher prices and face longer waiting lists — trend accelerating as DNA databases undermine true anonymity |
Source: coparents.com — Sperm Donor Compensation: 5 Essential Pay Facts (March 31, 2026); Ivy Surrogacy — How Much Do Sperm Donors Make in 2026 (April 1, 2026); Cryos International — Sperm Donor Pay and Compensation (cryosinternational.com); donatesperm.com — Sperm Donor Compensation and Pay; coparents.com — Sperm Donor Earnings (March 28, 2026); ASRM — Ethics Committee Report 2024; FDA 21 CFR Part 1271
The compensation structure for sperm donors operates under a careful ethical framework established by the American Society for Reproductive Medicine (ASRM), whose 2024 ethics guidance explicitly states that pay must cover time, inconvenience, and effort without being so high that financial need dominates as the primary motivator. In practice, this creates the $70–$200 per approved donation band that most commercial banks occupy, with total monthly earnings capped by visit frequency limits — typically once or twice per week. The Cryos International breakdown — $35 at donation, $30 for motility approval, $25 per batch — is one of the most transparent public illustrations of how split-payment systems function, and it shows why maximizing earnings requires consistent quality across every visit, not just showing up. The known/directed donation model through agencies — paying $5,000 to $50,000+ per engagement — represents a fundamentally different economic proposition with far less time commitment than the commercial bank model’s six-month weekly schedule, and it has grown alongside the trend toward identity-transparent donation.
The Colorado legislation effective in 2025 — making it the first US state to legally end anonymous sperm donation — reflects the direction of travel for the entire industry. Consumer DNA databases like 23andMe and AncestryDNA have already made it possible for donor-conceived individuals to identify biological donors regardless of any bank’s anonymity policy. Banks built on anonymous programs are now reconfiguring toward ID-release as the default — carrying cost implications for both sides: donors who prefer anonymity are harder to recruit, and recipients pay more for open-identity donors whose legal and administrative overhead is higher.
US Cryobank Market Structure & Key Trends in 2026
US CRYOBANK MARKET — KEY METRICS & TRENDS 2026
================================================
US Market Value (2026) ████████████████████ $1.9 Billion
Market CAGR to 2031 ████████████████████ 3.52%
Global Market (2026) ████████████████████ $5.38 Billion
Known/ID-release donors (2024) ████████████████████ 58.84% market share
Directed donors CAGR ████████████████████ 5.12% (fastest growing)
Female/single clients (Cryos, 2025) ████████████████████ 85% of Cryos clients
Fertility clinics' end-use share ████████████████████ ~50% of global market
Sperm freezing revenue share (2026) ████████████████████ ~42%
Scale: Each █ ≈ ~5 percentage points or proportional
| Market Structure / Trend | Statistic / Data |
|---|---|
| US sperm bank market value (2026) | $1.9 billion — CAGR 3.52% projected to 2031 (Mordor Intelligence, May 2026) |
| US market projected value by 2031 | $2.26 billion (Mordor Intelligence) |
| Global sperm bank market 2025–2026 | $5.15B (2025) → $5.38B (2026) — CAGR 4.51% to reach $7.01B by 2032 |
| North America market size (2024) | $2.2 billion → projected $4.8 billion by 2034 at 8.2% CAGR (Emergen Research) |
| Sperm freezing segment share (2026) | ~42% of global market revenue — fastest-growing service segment (Persistence Market Research) |
| Known/ID-release donor market share (2024) | 58.84% — majority of global market now transacts through identity-transparent donors |
| Directed/bespoke donor CAGR | 5.12% — fastest-growing donor category (Mordor Intelligence) |
| Leading US cryobanks | California Cryobank, Fairfax Cryobank, Xytex, Seattle Sperm Bank, Cryos International USA |
| Fertility clinics — end-use market share | ~50% globally — primary access point for ART services (Emergen Research) |
| Hospital market share | ~20% — oncofertility and reproductive health programs |
| Cryos International — global scale | Largest sperm bank in the world by available donors as of September 2025 (Wikipedia) |
| Cryos International — delivery reach | Delivers to more than 100 countries from Denmark + US locations in FL, NC, TX |
| Private equity — December 2024 | Astorg acquired Hamilton Thorne’s fertility equipment division for $228 million |
| California Cryobank — blockchain (May 2025) | Introduced blockchain-based donor identity systems for enhanced record transparency |
| Fairfax Cryobank — genetic screening (Feb 2025) | Partnered with major hospitals to expand genetic screening capabilities |
| Xytex — open-identity expansion (Jan 2025) | Announced expansion of open-identity donor programs across North America |
| Female/single women clients — Cryos (Sept 2025) | 85% of Cryos clients are lesbian couples or single women (Wikipedia / The Guardian, September 2025) |
| Total cost — one IUI pregnancy (estimate, 4 cycles) | $5,580–$8,780 in vials alone at $1,395–$2,195/vial × 4 cycles — before procedures, shipping, or storage |
Source: Mordor Intelligence — US Sperm Bank Market Report (May 2026); Research and Markets — Sperm Banks Market 2026; Emergen Research — Sperm Bank Market 2034; Wikipedia — Cryos International (September 2025); Persistence Market Research — Sperm Bank Market 2026; California Cryobank May 2025 announcement; Fairfax Cryobank February 2025 partnership announcement; Xytex January 2025 open-identity expansion
The structural evolution of the US cryobank market in 2026 is being driven by three forces simultaneously: rising infertility rates tied to delayed parenthood and environmental factors; growing social and legal recognition of diverse family structures, reflected in Cryos International’s remarkable statistic that 85% of its client base is now lesbian couples or single women; and the irreversible shift away from anonymous donation as DNA technology makes true anonymity impossible to guarantee. The fact that 58.84% of the global market transacts through known or ID-release donors — with the directed donor category growing at the fastest CAGR at 5.12% — confirms that the future of cryobanking is transparent, identity-disclosed, and more expensive per transaction than the anonymous model it is replacing.
The market consolidation trend — visible in the $228 million Astorg acquisition in December 2024 — signals institutional investor confidence in this sector as a high-growth, recession-resistant healthcare services market. The technological investment within individual banks — California Cryobank’s blockchain identity system (May 2025), Fairfax Cryobank’s hospital genetic screening partnerships (February 2025), Xytex’s open-identity expansion (January 2025) — confirms that competitive differentiation in 2026 is being won through transparency, genetic depth, and technological infrastructure. For families navigating this market, the takeaway is that the US cryobank sector in 2026 is more sophisticated, more expensive, more transparent, and accessible to a wider range of family structures than at any point in its history — and every indicator points to all four trends intensifying through the decade ahead.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.